
Centene Corporation (NYSE:CNC) reaffirmed its full-year adjusted diluted EPS forecast of $1.75 at the Deutsche Bank Healthcare Summit, citing July and August Medicaid results that support its targeted Health Benefits Ratio (HBR) improvement for the second half of 2025. The company also successfully refiled 2026 Marketplace rates in states covering 95% of its membership, a crucial step for future segment stability, with approvals pending through month-end.
Centene Corporation's management provided a constructive update, reaffirming its full-year 2025 adjusted diluted EPS forecast of $1.75. This guidance is supported by recent operational data, with Medicaid results from July and August indicating that the company is on the targeted trajectory for Health Benefits Ratio (HBR) improvement in the second half of the year, suggesting effective management of medical cost trends. Concurrently, the company is making significant headway in solidifying its 2026 outlook by successfully refiling for Marketplace rates in states that represent 95% of its membership. While this action de-risks a key operational hurdle, the final rate approvals from state regulators, expected by the end of September, remain a critical upcoming catalyst for the segment's future profitability.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.50
Ticker Sentiment